BioWorld - Friday, December 26, 2025
To read the full story, subscribe or sign in.
Cancer
Abbisko Therapeutics divulges new SMARCA2 inhibitors
Dec. 2, 2025
Abbisko Therapeutics Co. Ltd. has synthesized probable global transcription activator SNF2L2 (SMARCA2; BAF190B; SNF2-α) inhibitors reported to be useful for the treatment of cancer.
BioWorld ScienceCancerPatents